Do CVID patients on SCIG have more autoimmune (thrombo)cytopenic events than CVID patients on IVIG?

Autoimmune thrombocytopenia (AITP) is frequent in patients diagnosed with common variable immunodeficiency (CVID). High dose intravenous immunoglobulin treatment (IVIG) has conventionally been a cornerstone of the initial therapy for AITP. This study aimed to assess the safety and effectiveness of s...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nadezhda Camacho-Ordonez, Aleksandra Hirsch, Luiza Campos, Sigune Goldacker, Siobhan O. Burns, Fernando Moreira, Klaus Warnatz, Bodo Grimbacher
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-11-01
coleção:	Frontiers in Immunology
Assuntos:	autoimmune thrombocytopenia intravenous or subcutaneous immunoglobulin common variable immunodeficiency autoimmunity cytopenia
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1708813/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!